MindBio Therapeutics Corp. MBQIF Archives

ThursdayMay 21, 2026 9:45 am

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Expands AI Voice Platform with Fatigue Detection Module

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. MindBio Therapeutics is expanding its AI voice analytics platform to include fatigue detection alongside drug and alcohol impairment screening. MindBio filed a patent application covering detection of neurologically active substances and fatigue through voice analysis. Fatigue prediction module will be added to Edge AI Intoxication Detection Kiosks targeted at industrial workplaces. Management says commercial testing of kiosk hardware and software remains on track for late Q2 2026. The company is positioning its technology as a non-invasive alternative to breath, saliva, blood and laboratory-based testing…

TuesdayMay 19, 2026 2:26 pm

QualityStocksNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Advancing Workplace Safety with AI-Powered Technology

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. MindBio Therapeutics (CSE: MBIO) (OTCQB: MBQIF) is introducing a novel system aimed at identifying drug and alcohol impairment, initially focused on the South American mining sector, where remote operations and heavy machinery make safety monitoring critical. An article discussing this reads, “The biotechnology company, which has spent several years conducting research into intoxication detection, has developed a voice-based AI system designed to identify signs of alcohol or drug impairment within seconds, the first of its kind in the world. Instead of relying on traditional biological testing methods…

FridayMay 15, 2026 9:00 am

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) CEO Highlights AI Voice Detection Platform and Workplace Rollout Plans During TechMediaWire Podcast

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. During a recent TechMediaWire Podcast appearance, Justin Hanka outlined MindBio Therapeutics’ progress in developing advanced AI-driven voice analysis technology for drug and alcohol intoxication detection. MindBio Therapeutics Corp. says its prediction models are trained using more than 50 million data points collected through years of clinical and behavioral research. The company’s initial commercial strategy focuses on workplace safety sectors including mining, aviation, and construction, where impairment-related incidents carry significant operational and regulatory risks. Hanka said during the interview that the company’s voice-analysis platform can…

ThursdayMay 14, 2026 10:00 am

QualityStocksNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Featured in BioMedWire Editorial on Real-Time Intoxication Detection Technologies

This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising. MindBio Therapeutics (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) announced its featured placement in an editorial published by BioMedWire, highlighting emerging opportunities in real-time intoxication detection technologies. The editorial spotlights MindBio’s AI-driven voice analysis platform, which is being developed to detect impairment from brief speech recordings across a range of substances, addressing growing demand for faster, noninvasive and scalable intoxication detection solutions across healthcare, workplace safety and public health applications. To view the full press release, visit https://ibn.fm/1WCqA About MindBio Therapeutics Corp. MindBio is a…

WednesdayMay 13, 2026 9:10 am

QualityStocksNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Spotlighted in BioMedWire Editorial on AI-Driven Impairment Detection

This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising. MindBio Therapeutics (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) was featured in BioMedWire editorial coverage highlighting the growing demand for real-time, noninvasive impairment detection technologies, with the company positioned as a differentiated player leveraging artificial intelligence and voice analysis to identify intoxication from brief speech recordings. The editorial underscores the limitations of conventional detection tools such as breathalyzers, blood draws and urine testing, noting MindBio’s focus on scalable, real-time assessment across multiple substances for potential applications in workplace safety, law enforcement, healthcare and public health.…

TuesdayMay 12, 2026 10:00 am

QualityStocksNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) CEO Featured on TechMediaWire Podcast Discussing AI Voice Detection Platform

This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising. MindBio Therapeutics (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Founder and CEO Justin Hanka joined the latest episode of the TechMediaWire Podcast to discuss the company’s artificial intelligence-driven voice analysis technology designed to detect drug and alcohol intoxication through noninvasive speech analysis. During the interview, Hanka outlined the limitations of traditional testing methods and described MindBio’s commercial focus on regulated workplace environments such as mining, where the company believes its scalable detection platform could improve safety by expanding real-time intoxication screening capabilities. To view the…

TuesdayMay 12, 2026 9:20 am

QualityStocksNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Featured in BioMedWire Editorial on AI-Powered Intoxication Detection

This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising. MindBio Therapeutics (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) announced its placement in a BioMedWire editorial exploring emerging technologies aimed at improving intoxication detection across law enforcement, workplace safety and healthcare settings. The editorial highlights MindBio’s development of an artificial intelligence-driven voice analysis platform designed to detect real-time impairment from short speech samples, positioning the company within a growing movement toward noninvasive diagnostic technologies with potential applications across public safety, regulatory enforcement and health monitoring. To view the full press release, visit https://ibn.fm/Ib2KB About MindBio…

MondayMay 11, 2026 10:40 am

QualityStocksNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Expands AI Voice Diagnostics Platform With Fatigue Detection Technology

This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising. MindBio Therapeutics (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) announced the development of AI-powered fatigue recognition technology that analyzes voice patterns and is intended to be added as a commercial feature to the company’s Edge AI Intoxication Detection Kiosks. Designed for high-risk industries including aviation, road transport and mining, the fatigue detection module complements MindBio’s broader voice-based diagnostics platform aimed at identifying intoxication and neurological impairment, with initial commercial testing of the kiosk platform expected in late second quarter 2026. To view the full press…

MondayMay 11, 2026 10:00 am

QualityStocksNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Advances AI Voice-Based Intoxication Detection as Real-Time Diagnostics Market Expands

This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising. MindBio Therapeutics (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) is developing an AI-driven voice analysis platform designed to detect drug and alcohol intoxication in real time, addressing growing demand for faster, scalable and noninvasive impairment detection across workplace safety, healthcare and public safety markets. By leveraging speech as a diagnostic biomarker, the company is pursuing a differentiated approach to multisubstance intoxication detection within an evolving AI healthcare landscape that includes HeartFlow Inc. (NASDAQ: HTFL), Recursion Pharmaceuticals Inc. (NASDAQ: RXRX), Tempus AI Inc. (NASDAQ: TEM) and…

ThursdayMay 07, 2026 9:45 am

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Files Patent Applications for Voice-Based Intoxication Detection

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. The company has filed patent applications covering 15 novel discoveries in AI-driven voice intoxication detection. The platform analyzes speech patterns to estimate drug and alcohol impairment without physical samples. Initial commercial rollout is targeting mining and aviation via Edge AI kiosk systems, with Broader applications including call centers, law enforcement, and mental health screening. Technology is designed for high-volume, regulated environments where testing is costly and time consuming. The overall global drug and alcohol testing market is projected to reach $4.2 billion by 2033.…

Site Search

Company Search

Tag: MindBio Therapeutics Corp. MBQIF